Genezen News & Resources

Keep up to date with the latest news at Genezen, and explore our expert content around molecular biology news and insights.

Scroll Down

Filter

By type

By service

Genezen completes cGMP-lentiviral and retroviral vector…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more

Genezen announces launch of Scientific Advisory…

Leading experts in cell and gene therapy will provide guidance to...

Read more

Overcoming development and manufacturing challenges with…

As efficient and effective tools for gene transduction and delivering genes...

Read more

Retroviruses in CAR-T therapies: From gamma…

Introduction In recent years, chimeric antigen receptor T (CAR-T) cells have...

Read more

EPR: 2022 biopharma trend predictions roundtable

From supply challenges surrounding COVID-19 to regulatory changes and innovations, the...

Read more

World Pharma Today: 2022 biopharma trends…

The potential of both mRNA technologies and lipid nanoparticle (LNPs) have...

Read more
Load more

Get insights like this directly to your inbox

Sign up to our newsletter

Our solutions

From Process Development, Testing, GMP Vector Manufacturing to Cell Manufacturing

Our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to market with precision and speed.